Addressing chronic constipation in elderly patients remains a priority for clinicians in India due to the high prevalence of gastrointestinal issues in the aging population. Many patients rely on stimulant laxatives, yet these treatments often cause undesirable effects like dehydration and electrolyte disturbances. Consequently, a recent pilot study published in Minerva Gastroenterol explored a synbiotic solution to provide safer relief.

The research involved 50 participants with a mean age of 65.3 years. Initially, 72% of these patients reported having two or fewer complete spontaneous bowel movements (CSBMs) every week. However, after receiving a specific probiotic-prebiotic mix for 28 consecutive days, the clinical picture changed significantly. Notably, only 36% of patients still fell into that low-frequency category. Specifically, 64% of participants experienced an improvement of one to four CSBMs per week.

Managing Chronic Constipation in Elderly Patients

Furthermore, the synbiotic intervention improved several Quality of Life (QoL) metrics. Participants reported reduced abdominal pain and less bloating throughout the treatment duration. Moreover, the study reported no adverse events, which is crucial for frail patients with comorbidities. Therefore, this synbiotic mix offers a promising, well-tolerated alternative to conventional pharmacological agents.

Additionally, previous studies have highlighted that elderly populations often exhibit a marked decline in beneficial gut bacteria. By restoring Lactobacillus and Bifidobacterium levels, clinicians can enhance colonic transit time effectively. Therefore, integrating synbiotics into geriatric care protocols could reduce reliance on invasive enemas and improve overall patient satisfaction.

Frequently Asked Questions

What specific strains were included in the synbiotic mix?

The pilot study used a combination of Lactobacillus rhamnosus, Lactobacillus paracasei, Bifidobacterium animalis ssp. lactis, and Bifidobacterium breve.

How quickly can patients expect to see improvements?

According to the results, patients showed significant improvements in bowel transit and symptom relief within 28 days of consecutive treatment.

Is the probiotic-prebiotic mix safe for frail patients?

Yes, the study reported no adverse events among the elderly participants, suggesting the treatment is well-tolerated even in patients with potential comorbidities.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

Montarsolo P et al. Efficacy of a probiotic-prebiotic mix on chronic constipation symptoms in the elderly: results of a pilot study. Minerva Gastroenterol (Torino). 2026 Mar 13. doi: 10.23736/S2724-5985.26.03960-4. PMID: 41823986.

Lora AT et al. Supplementation with probiotics, prebiotics, and synbiotics in patients with chronic functional constipation: a randomized, double-blind, placebo-controlled pilot clinical trial. Gastroenterol Rep (Oxf). 2024 Nov 11;12:goae101.

Govindarajan S et al. Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38(1):76-103.